Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for sweating dysfunction in atopic dermatitis
jRCT1071200016Completed
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of dupilumab in atopic dermatitis (AD). Primary endpoint: Change in sweat volume and latency time in QSART. Started Jul 2020; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1071200016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071200016.